SI-Bone (United States)
company in Santa Clara, United States
SIBN Nasdaq
SEC CIK 1459839 LEI 549300J8JGYVJJHV9C31
Follow SI-Bone (United States)
Weekly email: filings, results
Revenue, last quarter
$55.7M
+14.5% vs same quarter last year
Net income
−$3.6M
+20.7% vs same quarter last year
EPS, diluted
−$0.08
+27.3% vs same quarter last year
Operating cash flow
$5.9M
+154.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $200.9M | −$18.9M |
| FY24 | $167.2M | −$30.9M |
| FY23 | $138.9M | −$43.3M |
| FY22 | $106.4M | −$61.3M |
| FY21 | $90.2M | −$56.6M |
| FY20 | $73.4M | −$43.7M |
| FY19 | $67.3M | −$38.4M |
| FY18 | $55.4M | −$17.5M |
| FY17 | $48M | −$23M |
| FY16 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 79.6% | −11.1% | −9.4% |
| FY24 | 79% | −21.1% | −18.5% |
| FY23 | 78.8% | −33.8% | −31.2% |
| FY22 | 85.2% | −56% | −57.6% |
| FY21 | 88.4% | −57.3% | −62.8% |
| FY20 | 87.9% | −52.6% | −59.5% |
| FY19 | 89.9% | −53.5% | −57.1% |
| FY18 | 91.3% | −21.6% | −31.5% |
| FY17 | 89.3% | −36.2% | −48% |
| FY16 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$9.1M |
| FY24 | −$22.9M |
| FY23 | −$26.5M |
| FY22 | −$51.2M |
| FY21 | −$45.9M |
| FY20 | −$33.2M |
| FY19 | −$34.1M |
| FY18 | −$15.5M |
| FY17 | −$18M |
| FY16 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | - |
| FY22 | - |
| FY21 | - |
| FY20 | - |
| FY19 | $38K |
| FY18 | $73K |
| FY17 | $0 |
| FY16 | - |
- SI-Bone (United States)
- Healthcare median
Show the numbers
| Year | SI-Bone (United States) | Healthcare median |
|---|---|---|
| FY25 | −9.4% | −30.6% |
| FY24 | −18.5% | −47% |
| FY23 | −31.2% | −58% |
| FY22 | −57.6% | −80.4% |
| FY21 | −62.8% | −71.8% |
| FY20 | −59.5% | −62.2% |
| FY19 | −57.1% | −46.2% |
| FY18 | −31.5% | −49.6% |
| FY17 | −48% | −45.9% |
| FY16 | - | −36% |